Improving medication adherence for breast cancer and cardiovascular disease
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
This study is looking for ways to help people with breast cancer and heart disease stick to their medication plans by creating a new support system that takes into account the unique needs of patients from different backgrounds, and it will involve 300 participants to see how well it works.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10897800 on NIH RePORTER |
What this research studies
This research investigates a new approach to help patients with breast cancer and cardiovascular disease take their medications as prescribed. It focuses on creating an intervention that considers the diverse needs of patients, particularly those from different racial and ethnic backgrounds. By involving patients and healthcare providers in the design process, the study aims to develop a more effective and equitable solution to medication nonadherence. The effectiveness of this intervention will be tested in a randomized controlled trial with 300 participants.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with a diagnosis of breast cancer or cardiovascular disease who struggle with medication adherence.
Not a fit: Patients who are not diagnosed with breast cancer or cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved medication adherence, resulting in better health outcomes and reduced disparities for patients with breast cancer and cardiovascular disease.
How similar studies have performed: Previous research has shown that addressing medication adherence through tailored interventions can be effective, but this approach emphasizes equity and is designed to be more scalable.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Hershman, Dawn — Columbia University Health Sciences
- Study coordinator: Hershman, Dawn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.